Literature DB >> 11583068

Triamcinolone: new and old indications.

S A Doggrell1.   

Abstract

Triamcinolone is a commonly used synthetic corticosteroid that has recently been tested in a large clinical trial for chronic obstructive pulmonary disease and shown to have some benefits. To our knowledge, there are no reviews of the pharmacotherapy of triamcinolone. This review has a brief overview of the pharmacology of triamcinolone, followed by a discussion of the clinical trials with triamcinolone. Triamcinolone is used in the treatment of respiratory inflammation, rheumatoid arthritis and a variety of other inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583068     DOI: 10.1517/14656566.2.7.1177

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  5 in total

Review 1.  Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.

Authors:  Gyan P Mishra; Viral Tamboli; Jwala Jwala; Ashim K Mitra
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2011-01

2.  Triamcinolone acetonide: a new management of noncompliance in nephrotic children.

Authors:  Tim Ulinski; Anne Carlier-Legris; Déborah Schlecht; Bruno Ranchin; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2005-04-21       Impact factor: 3.714

3.  Structural Analysis of the Glucocorticoid Receptor Ligand-Binding Domain in Complex with Triamcinolone Acetonide and a Fragment of the Atypical Coregulator, Small Heterodimer Partner.

Authors:  Emily R Weikum; C Denise Okafor; Emma H D'Agostino; Jennifer K Colucci; Eric A Ortlund
Journal:  Mol Pharmacol       Date:  2017-04-10       Impact factor: 4.436

4.  Role of steroid injection for skin thickness and edema in rhinoplasty patients.

Authors:  Canset Aydın; Ömer Taşkın Yücel; Seray Akçalar; Gamze Atay; Serdar Özer; Tevfik Sözen; Deniz Akata
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-07-09

5.  Hypothalamic-pituitary-adrenal axis function following intravitreal triamcinolone acetonide injection.

Authors:  Maoz D Amiran; Sonia N Yeung; Yaron Lang; Gil Sartani; Avraham Ishay; Rafael Luboshitzky
Journal:  Int Ophthalmol       Date:  2012-11-07       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.